MA1-treated A2780S cells showed a different RNA profile than MA1-treated A2780CP, in which two of the genes (Bcl2 and Caspases9) showed different expression patterns in the sensitive ovarian cancer cells upon treatment (Figure 6A). This evidence concerns the gene BCL2 and ovarian carcinoma.